Results 1 to 10 of about 26,191 (234)
Diagnosis and Treatment of Tracheal or Bronchuotracheal Adenoid Cystic Carcinoma [PDF]
Chinese Journal of Lung Cancer, 2010 Background and objective Adenoid cystic carcinoma is primary bronchopulmonary carcinoma with low malignancy, and 43 patients treated in the past 50 years in our hospital were retrospectively studied.
Ming QIN +5 more
doaj +1 more source
Adenoid cystic carcinoma: emerging role of translocations and gene fusions. [PDF]
, 2016 Adenoid cystic carcinoma (ACC), the second most common salivary gland malignancy, is notorious for poor prognosis, which reflects the propensity of ACC to progress to clinically advanced metastatic disease.
Brait, Mariana +5 more
core +8 more sources
Adenoid Cystic Carcinoma of the Trachea [PDF]
Indian Journal of Surgical Oncology, 2015 Adenoid cystic carcinoma is very rare, with an incidence of 0.1 to 0.26 per one lakh people. It is the second most common primary malignancy of the trachea. The etiology, clinical manifestation and prognosis of ACC trachea in Indian scenario has not been discussed so far.
Santhosh, Kumar N +3 more
openaire +5 more sources
The Birth of an Adenoid Cystic Carcinoma [PDF]
International Journal of Surgical Pathology, 2014 In situ adenoid cystic carcinoma (arrows) partially involving a duct (A; hematoxylin and eosin) associated with a primary adenoid cystic carcinoma of the breast (upper part of the micrograph). The partially involved duct contained nonneoplastic CK7-positive luminal cells (B), some of which were estrogen receptor–positive (C), and an in situ adenoid ...
N. Fusco +5 more
openaire +2 more sources
Journal of Medical Imaging and Radiation Oncology, EarlyView., 2023 Summary Proton Beam Therapy (PBT) has the potential to improve paediatric cancer care by reducing radiation exposure and thus long‐term toxicities. Ethical concerns and debates surrounding the treatment, such as eligibility and accessibility, are ongoing in Australia. The Australian Bragg Centre for Proton Therapy and Research (ABCPTR) (named after Sir
Jeremy Khong +10 more
wiley +1 more source
Journal of Translational Medicine, 2010 Background Adenoid cystic carcinoma is one of the most common types of salivary gland cancers. The poor long-term prognosis for patients with adenoid cystic carcinoma is mainly due to local recurrence and distant metastasis.
Zhang Zhiyuan +3 more
doaj +1 more source
Adenoid Cystic Carcinoma of the Buccal Mucosa: A Case Report with Review of Literature [PDF]
Journal of Clinical and Diagnostic Research, 2014 Minor salivary gland neoplasms of the buccal mucosa are relatively uncommon. Adenoid cystic carcinoma (ACC), a well-defined entity, occurs most of the times in the parotid, submandibular glands and palate, as far as the intraoral site is concerned ...
VIDYALAKSHMI S., ARAVINDHAN R.
doaj +1 more source
Archives of Pathology & Laboratory Medicine, 2011 Abstract Adenoid cystic carcinoma is a malignant tumor with a deceptively benign histologic appearance characterized by indolent, locally invasive growth with high propensity for local recurrence and distant metastasis. The tumor is composed of basaloid cells with small, angulated, and hyperchromatic nuclei and scant cytoplasm ...
Jesse, Jaso, Reenu, Malhotra
openaire +2 more sources
Adenoid cystic carcinoma of the buccal mucosa: A case report and review of the literature
Dental Research Journal, 2012 Adenoid cystic carcinomas are deceptive malignancies that show slow growth and local invasion with recurrences seen many years after diagnosis. Upto 50% of these tumors occur in the intraoral minor salivary glands usually in the hard palate.
Vidya Ajila +3 more
doaj +1 more source
Case Report: Efficacy of Pyrotinib in ERBB2 Amplification Pulmonary Adenoid Cystic Carcinoma
Frontiers in Oncology, 2021 Primary pulmonary adenoid cystic carcinomas are salivary tumors that are low-grade malignant and prone to recurrence and metastasis. Surgery is currently the main treatment, but there is no standard with regard to postoperative adjuvant therapy.
Zhongben Tang +8 more
doaj +1 more source